Keyphrases
Mycosis Fungoides
99%
Cutaneous Lymphoma
24%
Cutaneous T-cell Lymphoma
18%
Sézary Syndrome
16%
Pediatric
14%
Advanced Stage
13%
Folliculotropic
11%
Primary Cutaneous B-cell Lymphoma
10%
Single-center Experience
10%
International Consortium
10%
Plaque
9%
Rash
7%
Epidermal Growth Factor Receptor Inhibitors
7%
Psoriasis
7%
Tertiary Care Hospital
7%
Multicenter Retrospective Cohort Study
6%
International Prognostic Index
6%
Dasatinib
6%
Global Patterns
6%
Nilotinib
6%
Retrospective Follow-up
6%
MicroRNA-155 (miR-155)
6%
Patterns of Care
6%
Ixekizumab
6%
Monotherapy
6%
Ultraviolet-B (UV-B)
6%
Overall Response Rate
5%
Hyperpigmented
5%
Complete Response
5%
Medicine and Dentistry
Mycosis fungoides
100%
Cutaneous Lymphoma
23%
Disease
21%
Cutaneous T Cell Lymphoma
17%
Sezary Syndrome
15%
Pediatrics
14%
Retrospective Cohort Study
10%
Neoplasm
10%
B-Cell Lymphoma
10%
Exanthem
8%
Psoriasis
7%
International Prognostic Index
6%
Oncology
6%
Nilotinib
6%
Dasatinib
6%
microRNA 155
6%
microRNA
6%
Lymphoma Cell
6%
Photopheresis
5%
MALT Lymphoma
5%
Dermatology
5%
Side Effect
5%
Psoralen
5%
Cytotoxicity
5%